People with aphasia-a brain disorder affecting about a million people in the U.S.-struggle to turn their thoughts into words and comprehend spoken language.
ASU professor offers insights on what may be coming from Neuralink’s PRIME study
This week, Neuralink’s Elon Musk announced that human clinical trials have begun on its Precise Robotically Implanted Brain-Computer Interface (PRIME) study, a medical device trail